Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-22

Clinical Trial Update: Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Vitamin D3 (cholecalciferol) substitution in vitamin D-deficient kidney transplant recipients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Medical University of Vienna | Conditions: Kidney Transplantation, Vitamin D Deficiency | Phase 3 | Status: UNKNOWN